Funds holding Rapport Therapeutics Inc
ISIN US75383L1026 · United States
- Fund holders
- 162
- Of which ETFs
- 37 125 other funds
- Value held
- 435M $ 33.7M SEK
- Share of capital
- 29.8 % of 48M shares on Aug 3, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Avantis U.S. Small Cap Equity Fund American Century ETF Trust | 3,399 | 98.7K $ | 0.08 % | 0.01 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Health Care ETF T. Rowe Price Exchange-Traded Funds, Inc. | 3,392 | 106.1K $ | 0.52 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 3,354 | 111.1K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Small-Cap Index Fund T. ROWE PRICE INDEX TRUST, INC. | 3,308 | 103.5K $ | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Variable Insurance Trust Small Cap Equity Insights Fund Goldman Sachs Variable Insurance Trust | 3,221 | 100.8K $ | 0.05 % | 0.01 % | as of Mar 31, 2026 ↗ |
| SA Small Cap Index Portfolio SUNAMERICA SERIES TRUST | 3,213 | 106.4K $ | 0.03 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Voya RussellTM Small Cap Index Portfolio Voya VARIABLE PORTFOLIOS INC | 3,062 | 95.8K $ | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Invesco Russell 2000 Dynamic Multifactor ETF Invesco Exchange-Traded Self-Indexed Fund Trust | 2,981 | 86.5K $ | 0.03 % | 0.01 % | as of Feb 28, 2026 ↗ |
| U.S. Small Cap Equity Fund RUSSELL INVESTMENT FUNDS | 2,684 | 84K $ | 0.04 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 2,657 | 77.1K $ | 0.10 % | 0.01 % | as of Feb 28, 2026 ↗ |
| SA T. Rowe Price Allocation Moderately Aggressive Portfolio SUNAMERICA SERIES TRUST | 2,538 | 84.1K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| PD Small-Cap Value Index Portfolio PACIFIC SELECT FUND | 2,424 | 75.8K $ | 0.06 % | 0.01 % | as of Mar 31, 2026 ↗ |
| CVT Russell 2000 Small Cap Index Portfolio Calvert Variable Trust, Inc. | 2,310 | 72.3K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nationwide Small Cap Index Fund Nationwide Mutual Funds | 2,291 | 75.9K $ | 0.03 % | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD RUSSELL 3000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 2,260 | 65.6K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Goldman Sachs Small Cap Growth Insights Fund Goldman Sachs Trust | 2,256 | 74.7K $ | 0.03 % | 0.00 % | as of Apr 30, 2026 ↗ |
| iShares MSCI World Small-Cap ETF iShares Trust | 2,225 | 64.6K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 2,201 | 63.9K $ | 0.07 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Venerable Small Cap Index Fund Venerable Variable Insurance Trust | 2,130 | 66.6K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Strategic Equity Allocation Trust John Hancock Variable Insurance Trust | 2,063 | 64.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Innovator U.S. Small Cap Managed Floor ETF Innovator ETFs Trust | 1,961 | 65K $ | 0.08 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Avantis U.S. Equity ETF American Century ETF Trust | 1,854 | 53.8K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Voya VACS Index Series SC Portfolio Voya VARIABLE PORTFOLIOS INC | 1,786 | 55.9K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Russell2000 ProShares Trust | 1,761 | 51.1K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares UltraPro Russell2000 ProShares Trust | 1,757 | 51K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| SA U.S. Small Company Fund SA FUNDS INVESTMENT TRUST | 1,648 | 51.6K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares Total U.S. Stock Market Index Fund BlackRock Funds | 1,625 | 53.8K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| iShares Neuroscience and Healthcare ETF iShares Trust | 1,610 | 53.3K $ | 1.03 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PGIM Quant Solutions Small-Cap Value Fund Target Portfolio Trust | 1,400 | 46.4K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Small-Cap Equity Portfolio PACIFIC SELECT FUND | 1,328 | 41.6K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 High Income ETF ProShares Trust | 1,235 | 35.9K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 1,182 | 37K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Equity Market ETF Dimensional ETF Trust | 1,102 | 36.5K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 1,093 | 31.7K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Eventide Small Cap ETF Strategy Shares | 1,068 | 35.4K $ | 0.14 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PHARMACEUTICALS ULTRASECTOR PROFUND ProFunds | 1,012 | 33.5K $ | 0.99 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SmallCap Value Fund II Principal Funds, Inc | 949 | 31.4K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 940 | 29.4K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 800 | 25K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 784 | 24.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 671 | 19.5K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 661 | 20.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 501 | 15.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 419 | 13.9K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 406 | 13.5K $ | 0.09 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 394 | 12.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 331 | 11K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Innovation Leaders ETF T. Rowe Price Exchange-Traded Funds, Inc. | 326 | 10.2K $ | 0.07 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust | 258 | 8.5K $ | 0.11 % | 0.00 % | as of Apr 30, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 245 | 8.1K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 171 | 5.7K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 141 | 4.4K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 98 | 3.1K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Kennedy Capital Small Cap Growth Fund INVESTMENT MANAGERS SERIES TRUST II | 95 | 3K $ | 0.60 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 74 | 2.3K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 65 | 2K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 54 | 1.8K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 45 | 1.4K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 39 | 1.2K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 29 | 841.9 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 8 | 232.2 $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 7 | 219 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF SPDR SERIES TRUST | 1.37 % | as of Mar 31, 2026 ↗ |
| PROFUND VP PHARMACEUTICALS ProFunds | 1.31 % | as of Mar 31, 2026 ↗ |
| iShares Neuroscience and Healthcare ETF iShares Trust | 1.03 % | as of Apr 30, 2026 ↗ |
| Direxion Daily Pharmaceutical & Medical Bull 3X Shares Direxion Shares ETF Trust | 1.01 % | as of Apr 30, 2026 ↗ |
| PHARMACEUTICALS ULTRASECTOR PROFUND ProFunds | 0.99 % | as of Apr 30, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 0.89 % | as of Feb 28, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.81 % | as of Apr 30, 2026 ↗ |
| Kennedy Capital Small Cap Growth Fund INVESTMENT MANAGERS SERIES TRUST II | 0.60 % | as of Mar 31, 2026 ↗ |
| Zacks Small-Cap Core Fund Zacks Trust | 0.58 % | as of Feb 28, 2026 ↗ |
| NORTH SQUARE KENNEDY MICROCAP FUND Exchange Place Advisors Trust | 0.53 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 161 | +14 | 14,174,314 | +2.6 % |
| 2026Q1 | 147 | +32 | 13,811,328 | +18.5 % |
| 2025Q4 | 115 | +6 | 11,655,539 | +7.3 % |
| 2025Q3 | 109 | -10 | 10,864,370 | +9.1 % |
| 2025Q2 | 119 | +8 | 9,958,966 | +20.4 % |
| 2025Q1 | 111 | +23 | 8,273,373 | +4.2 % |
| 2024Q4 | 88 | +68 | 7,941,210 | +87.7 % |
| 2024Q3 | 20 | 4,231,874 |
Institutional managers
140 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| FMR LLC | 7,168,939 | 224.3M $ | as of Mar 31, 2026 |
| TRV GP V, LLC | 7,135,233 | 223.3M $ | as of Mar 31, 2026 |
| ARCH Venture Management, LLC | 3,728,738 | 116.7M $ | as of Mar 31, 2026 |
| Capital International Investors | 3,097,973 | 96.9M $ | as of Mar 31, 2026 |
| Cormorant Asset Management, LP | 2,957,521 | 92.5M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 2,942,251 | 92.1M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 2,505,955 | 78.4M $ | as of Mar 31, 2026 |
| Sofinnova Investments, Inc. | 1,904,408 | 59.6M $ | as of Mar 31, 2026 |
| JOHNSON & JOHNSON | 1,784,517 | 55.8M $ | as of Mar 31, 2026 |
| Polar Capital Holdings Plc | 1,642,461 | 51.4M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 1,547,090 | 48.4M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 1,436,229 | 44.9M $ | as of Mar 31, 2026 |
| TRV GP VI, LLC | 969,218 | 30.3M $ | as of Mar 31, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 918,866 | 28.8M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 866,456 | 27.1K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 759,552 | 23.8M $ | as of Mar 31, 2026 |
| ALLIANCEBERNSTEIN L.P. | 727,843 | 22.1M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 721,622 | 22.6M $ | as of Mar 31, 2026 |
| PERCEPTIVE ADVISORS LLC | 673,923 | 21.1M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 641,469 | 20.1M $ | as of Mar 31, 2026 |
| T. Rowe Price Investment Management, Inc. | 620,600 | 19.4K $ | as of Mar 31, 2026 |
| Capital World Investors | 536,607 | 16.8M $ | as of Mar 31, 2026 |
| Sio Capital Management, LLC | 366,809 | 11.5M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 319,552 | 10M $ | as of Mar 31, 2026 |
| KENNEDY CAPITAL MANAGEMENT LLC | 257,431 | 8.1M $ | as of Mar 31, 2026 |
Declared shareholders of Rapport Therapeutics Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Cormorant Asset Management, LP and 1 other | 6.19 % | 2,957,521 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Rapport Therapeutics Inc". https://titelia.com/en/stocks/rapport-therapeutics-inc-US75383L1026